BR112017017840A2 - composição compreendendo sialil-lactose para uso na melhora das capacidades de aprendizado e função de memória - Google Patents

composição compreendendo sialil-lactose para uso na melhora das capacidades de aprendizado e função de memória

Info

Publication number
BR112017017840A2
BR112017017840A2 BR112017017840A BR112017017840A BR112017017840A2 BR 112017017840 A2 BR112017017840 A2 BR 112017017840A2 BR 112017017840 A BR112017017840 A BR 112017017840A BR 112017017840 A BR112017017840 A BR 112017017840A BR 112017017840 A2 BR112017017840 A2 BR 112017017840A2
Authority
BR
Brazil
Prior art keywords
sialyl lactose
memory function
composition
learning abilities
improving learning
Prior art date
Application number
BR112017017840A
Other languages
English (en)
Other versions
BR112017017840B1 (pt
Inventor
Wang Bing
Shi Yujie
Dong Zhizhong
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112017017840A2 publication Critical patent/BR112017017840A2/pt
Publication of BR112017017840B1 publication Critical patent/BR112017017840B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04Disaccharides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicon Polymers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)

Abstract

a presente invenção refere-se ao uso de uma composição nutricional que compreende oligossacarídeos sialilados para melhorar o desenvolvimento cognitivo e as capacidades de aprendizado em mamíferos. a composição nutricional compreende 3'-sialil-lactose (3'-sl) e 6'-sialil-lactose (6'-sl) em uma razão em peso entre 10:1 e 1:10 e é especificamente para uso na melhora da capacidade de aprendizado e/ou na melhora da função de memória de um indivíduo através do aumento da concentração de ácido siálico (neu5ac) no cérebro do dito indivíduo.
BR112017017840-0A 2015-03-18 2016-03-17 Composição nutricional, bem como uso de 3'-sialil lactose (3'-sl) e 6'-sialil-lactose (6'-sl) BR112017017840B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/CN2015/074457 WO2016145628A1 (en) 2015-03-18 2015-03-18 Composition comprising siallyllactose for use in enhancing learning skills and memory function
CNPCT/CN2015/074457 2015-03-18
PCT/EP2016/055890 WO2016146789A1 (en) 2015-03-18 2016-03-17 Compostion comprising siallyllactose for use in enhancing learning skills and memory function

Publications (2)

Publication Number Publication Date
BR112017017840A2 true BR112017017840A2 (pt) 2018-04-10
BR112017017840B1 BR112017017840B1 (pt) 2022-10-25

Family

ID=56918404

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017840-0A BR112017017840B1 (pt) 2015-03-18 2016-03-17 Composição nutricional, bem como uso de 3'-sialil lactose (3'-sl) e 6'-sialil-lactose (6'-sl)

Country Status (11)

Country Link
US (2) US11528928B2 (pt)
EP (1) EP3270714A1 (pt)
CN (1) CN107427057A (pt)
AU (2) AU2016232084A1 (pt)
BR (1) BR112017017840B1 (pt)
CL (1) CL2017002184A1 (pt)
MX (2) MX2017011498A (pt)
MY (1) MY197396A (pt)
PH (1) PH12017550052A1 (pt)
RU (1) RU2770223C2 (pt)
WO (2) WO2016145628A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7125348B2 (ja) * 2016-01-13 2022-08-24 ベネバイオシス カンパニー リミテッド PGC-1αの発現を増加させる組成物
CA3030809A1 (en) 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Sialyloligosaccharide product and process
EP3629770A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
AU2018272156B2 (en) 2017-05-24 2024-05-30 Societe Des Produits Nestle S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
AU2018274636B2 (en) * 2017-05-24 2024-05-02 Societe Des Produits Nestle S.A. Composition comprising Human Milk Oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits
US11701404B2 (en) 2017-12-01 2023-07-18 Societe Des Produits Nestle S.A. Human milk fortifier composition
US20210267252A1 (en) * 2018-06-25 2021-09-02 Societe Des Produits Nestle S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
CN112218546B (zh) * 2018-06-25 2024-05-24 雀巢产品有限公司 包含用于改善、增强、促进或调节中枢神经系统中gaba能功能的人乳低聚糖的组合物
CN108835262B (zh) * 2018-07-19 2021-08-27 澳优乳业(中国)有限公司 一种改善记忆力的调制乳粉及其制备方法
EP3934656A1 (en) * 2019-03-05 2022-01-12 Société des Produits Nestlé S.A. A nutritional composition for use to enhance executive function
US20220160013A1 (en) * 2019-03-05 2022-05-26 Glycom A/S Human milk oligosaccharides for use in enhancing executive function
WO2020259540A1 (zh) * 2019-06-25 2020-12-30 嘉必优生物技术(武汉)股份有限公司 唾液酸类化合物在制备治疗脑部退行性病变药物或营养添加剂或食品中的应用
EP4072321A1 (en) * 2019-12-09 2022-10-19 Société des Produits Nestlé S.A. Compositions comprising human milk oligosaccharides for use in a subject to support language development
CN111387284A (zh) * 2020-04-28 2020-07-10 江苏集萃工业生物技术研究所有限公司 一种燕窝酸牛奶及其制备方法
CN114487255A (zh) * 2020-10-23 2022-05-13 内蒙古伊利实业集团股份有限公司 一种乳粉或乳清粉中唾液酸含量的检测方法
EP4313064A1 (en) * 2021-03-22 2024-02-07 Société des Produits Nestlé S.A. Human milk oligosaccharides
CN116189909B (zh) * 2023-03-06 2024-02-20 佳木斯大学 基于推举算法的临床医学判别方法及系统

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US20060247153A1 (en) 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
NZ602370A (en) 2010-03-12 2014-11-28 Dsm Ip Assets Bv Maternal sialic acid supplementation
EP2775852B1 (en) * 2011-10-18 2016-08-17 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
EP2880993A1 (en) * 2013-12-04 2015-06-10 Abbott Laboratories Method of achieving memory and learning improvement by the administration of sialic acid
US20150305384A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics

Also Published As

Publication number Publication date
WO2016146789A1 (en) 2016-09-22
MX2023005755A (es) 2023-06-08
AU2020230318A1 (en) 2020-10-01
MX2017011498A (es) 2018-01-11
PH12017550052A1 (en) 2018-01-29
AU2020230318B2 (en) 2022-12-01
US20230095436A1 (en) 2023-03-30
AU2016232084A1 (en) 2017-08-10
EP3270714A1 (en) 2018-01-24
US11528928B2 (en) 2022-12-20
RU2017135296A3 (pt) 2019-09-10
US20180064152A1 (en) 2018-03-08
CN107427057A (zh) 2017-12-01
WO2016145628A1 (en) 2016-09-22
BR112017017840B1 (pt) 2022-10-25
CL2017002184A1 (es) 2018-05-04
RU2770223C2 (ru) 2022-04-14
MY197396A (en) 2023-06-15
RU2017135296A (ru) 2019-04-09

Similar Documents

Publication Publication Date Title
BR112017017840A2 (pt) composição compreendendo sialil-lactose para uso na melhora das capacidades de aprendizado e função de memória
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112018015097A2 (pt) composição e reatores
BR112014008944A2 (pt) composição para uso no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
BRPI1009860A8 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
BRPI1011089A8 (pt) Composição nutricional para estimular o desenvolvimento e a função cerebral de crianças.
BR112017005840A2 (pt) processos para preparar uma solução aquosa de acrilamida, reduzir concentração de ácido acrílico de uma solução aquosa de acrilamida, solução aquosa de acrilamida, homopolímero ou copolímero de acrilamida, e, solução de um homopolímero e/ou copolímero de acrilamida.
BR112015014420A2 (pt) oligossacarídeos do leite humano para melhorar sintomas de estresse
BR112015016358A2 (pt) composições nutritivas contendo um componente neurológico e usos das mesmas
BR112014005197A2 (pt) fixação de septos em estrutura alveolar acústica
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
BR112017006416A2 (pt) composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico
BR112012016726A2 (pt) "processo para isolar uma composição de proteínas e uma composição de gorduras de aparas de carne"
BR112015002372A2 (pt) composições e métodos para a redução do teor de álcool no sangue
BR112015011931A2 (pt) composições nutricionais contendo treonato de magnésio e usos das mesmas
BR112017002627A2 (pt) prebióticos para reduzir o risco de obesidade no futuro
BR112013025976A2 (pt) produto alimentício a base de fruta
BR102015012091A8 (pt) método para a preparação de uma solução de albumina humana, e, composição
BR112019011802A2 (pt) composições nutricionais contendo butirato e/ou lactoferrina e usos das mesmas
BR112018067423A2 (pt) composições que compreendem colina e uso das mesmas
BR112015008031A2 (pt) composição cosmética sólida, processo para a sua produção, produto e método cosmético
BR112017008747A2 (pt) composições nutricionais contendo um prebiótico e lactoferrina e seus usos
BR112014016346A2 (pt) uso de glutamina ou de uma composição
BR112015020568A2 (pt) composição para melhorar o desenvolvimento cognitivo, cerebral e/ou do snc do recém-nascido e método para o uso da mesma

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: RETIFICA-SE O DEFERIMENTO DA RPI 2692 DE 09/08/2022 POR TER SIDO EFETUADO COM INCORRECAO.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/03/2016, OBSERVADAS AS CONDICOES LEGAIS